Lee W Young
Supervisory Patent Examiner (ID: 5212, Phone: (571)272-4549 , Office: P/3902 )
Art Unit(s) | 3103, 3613, 3902, OITP, 2855, 2899, 3727, 3729 |
Total Applications | 106452 |
Issued Applications | 502 |
Pending Applications | 104222 |
Abandoned Applications | 99 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16760952
[patent_doc_number] => 20210106533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => INDIGENOUS AND IMPROVED BACTERIALLY FERMENTED CBD, CBG AND RELATED CANNABINOID ORAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/861679
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861679 | Indigenous and improved bacterially fermented CBD, CBG and related cannabinoid oral dosage forms | Apr 28, 2020 | Issued |
Array
(
[id] => 17719043
[patent_doc_number] => 20220211762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/607389
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607389 | PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS OR SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT | Apr 26, 2020 | Pending |
Array
(
[id] => 16831010
[patent_doc_number] => 11007240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Composition containing saponins of
[patent_app_type] => utility
[patent_app_number] => 16/854905
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4155
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854905 | Composition containing saponins of | Apr 21, 2020 | Issued |
Array
(
[id] => 16422235
[patent_doc_number] => 20200347433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => METHODS FOR TREATING POLYMICROBIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/848651
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848651 | Methods for treating polymicrobial infections | Apr 13, 2020 | Issued |
Array
(
[id] => 16504112
[patent_doc_number] => 20200383368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => METHODS AND PRODUCTS TO PROVIDE ORAL NUTRITIONAL CARE TO SUBJECTS WITH DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 16/847929
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847929 | Methods and products to provide oral nutritional care to subjects with dementia | Apr 13, 2020 | Issued |
Array
(
[id] => 16183035
[patent_doc_number] => 10716322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-07-21
[patent_title] => Oral/enteral vegetarian food compositions and method of manufacturing the same
[patent_app_type] => utility
[patent_app_number] => 16/842725
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9920
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842725 | Oral/enteral vegetarian food compositions and method of manufacturing the same | Apr 6, 2020 | Issued |
Array
(
[id] => 16174776
[patent_doc_number] => 20200221744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => GLUCOSYLATED STEVIOL GLYCOSIDE AS A FLAVOR MODIFIER
[patent_app_type] => utility
[patent_app_number] => 16/835103
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835103 | Glucosylated steviol glycoside as a flavor modifier | Mar 29, 2020 | Issued |
Array
(
[id] => 17058958
[patent_doc_number] => 11103540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Methods and compositions of biocontrol of plant pathogens
[patent_app_type] => utility
[patent_app_number] => 16/829347
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10714
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829347 | Methods and compositions of biocontrol of plant pathogens | Mar 24, 2020 | Issued |
Array
(
[id] => 16397342
[patent_doc_number] => 20200338200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => Stable liquid formulations for pharmaceuticals and supplements
[patent_app_type] => utility
[patent_app_number] => 16/827529
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827529
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827529 | Stable liquid formulations for pharmaceuticals and supplements | Mar 22, 2020 | Abandoned |
Array
(
[id] => 17967005
[patent_doc_number] => 11484509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Mint mask and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/824177
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5948
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16824177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/824177 | Mint mask and methods of use thereof | Mar 18, 2020 | Issued |
Array
(
[id] => 17593692
[patent_doc_number] => 20220143265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ACOUSTIC EXTRACELLULAR MATRIX HYDROGELS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/434925
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434925 | ACOUSTIC EXTRACELLULAR MATRIX HYDROGELS AND THEIR USE | Mar 11, 2020 | Pending |
Array
(
[id] => 17312852
[patent_doc_number] => 20210401900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => ENTERIC COMPOSITION, FOOD OR BEVERAGE PRODUCT CONTAINING THE SAME, METHOD FOR CONTROLLING DISINTEGRATION TIME OF THE SAME, AND METHOD FOR MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/768895
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768895
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768895 | ENTERIC COMPOSITION, FOOD OR BEVERAGE PRODUCT CONTAINING THE SAME, METHOD FOR CONTROLLING DISINTEGRATION TIME OF THE SAME, AND METHOD FOR MANUFACTURING THE SAME | Mar 10, 2020 | Abandoned |
Array
(
[id] => 16310855
[patent_doc_number] => 20200289593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => SPIRULINA CAROTENOID COMPLEX
[patent_app_type] => utility
[patent_app_number] => 16/815742
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815742
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/815742 | SPIRULINA CAROTENOID COMPLEX | Mar 10, 2020 | Abandoned |
Array
(
[id] => 17937065
[patent_doc_number] => 11471497
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-18
[patent_title] => Copper chelation therapeutics
[patent_app_type] => utility
[patent_app_number] => 16/812237
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 41593
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/812237 | Copper chelation therapeutics | Mar 5, 2020 | Issued |
Array
(
[id] => 17441842
[patent_doc_number] => 20220062347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => INDUCTION METHOD FOR MACROPHAGE, ANTI-INFLAMMATORY MACROPHAGE-INDUCING AGENT, AND PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/435437
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435437 | INDUCTION METHOD FOR MACROPHAGE, ANTI-INFLAMMATORY MACROPHAGE-INDUCING AGENT, AND PHARMACEUTICAL COMPOSITION | Mar 5, 2020 | Pending |
Array
(
[id] => 16703143
[patent_doc_number] => 10953056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression
[patent_app_type] => utility
[patent_app_number] => 16/806704
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16993
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806704 | Natural product compositions for treating or managing symptoms of ADD, ADHD, anxiety, and depression | Mar 1, 2020 | Issued |
Array
(
[id] => 16221294
[patent_doc_number] => 20200246410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => BAUHINIA EXTRACT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/799158
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799158 | None | Feb 23, 2020 | Issued |
Array
(
[id] => 17561708
[patent_doc_number] => 20220125857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/427685
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427685
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427685 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | Feb 6, 2020 | Pending |
Array
(
[id] => 17921599
[patent_doc_number] => 11464820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Fruit or vegetable pomace composition and use as blood glucose modulator and anti-diabetic agent
[patent_app_type] => utility
[patent_app_number] => 16/783962
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 31
[patent_no_of_words] => 28713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783962 | Fruit or vegetable pomace composition and use as blood glucose modulator and anti-diabetic agent | Feb 5, 2020 | Issued |
Array
(
[id] => 17405981
[patent_doc_number] => 11246841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Compositions and methods for treatment of erectile disfunction
[patent_app_type] => utility
[patent_app_number] => 16/745862
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3366
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16745862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/745862 | Compositions and methods for treatment of erectile disfunction | Jan 16, 2020 | Issued |